logo

CDXS

CodexisยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

CDXS Profile

Codexis, Inc.

A leading enzyme engineering company enabling the promise of synthetic biology

Pharmaceutical
--
04/22/2010
NASDAQ Stock Exchange
188
12-31
Common stock
200 Penobscot Drive , Redwood City , California 94063
--
Codexis, Inc., was incorporated in Delaware in January 2002. Its patented technology platform can create optimized biocatalysts that make existing industrial production processes faster, cleaner and more efficient, and can enable new industrial processes to have the potential for commercial scale. The company has commercialized its biocatalysts in the pharmaceutical industry and, after years of research and development cooperation with Shell, is starting to develop biocatalysts for the production of advanced biofuels. The company also leverages its technology platform to pursue solutions with biocatalyst capabilities in other bioindustrial markets, including carbon management, chemicals and water treatment.